Vanc Pharmaceuticals Inc.

Vanc Pharmaceuticals Inc.

September 16, 2014 16:42 ET

Vanc Pharmaceuticals Inc.: OTC Name Change in Effect

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 16, 2014) - VANC PHARMACEUTICALS INC. (the "Company" or "VANC") (TSX VENTURE:NPH)(OTCQB:NUVPF) is pleased to announce that its name has been changed with the Finance Industry Regulatory Authority in the US from Nuva Pharmaceuticals Inc. to Vanc Pharmaceuticals Inc. The trading symbol remains the same and is NUVPF.

This symbol is effective with all quote providers servicing US exchanges.

On behalf of: VANC Pharmaceuticals Inc.

Jamie Lewin, Director and CFO

Cautionary Note Regarding Forward-looking Statements: Information in this press release that involves VANC's expectations, plans, intentions or strategies regarding the future are forward-looking statements that are not facts and involve a number of risks and uncertainties. VANC generally uses words such as "outlook," "will," "could," "would," "might," "remains," "to be," "plans," "believes," "may," "expects," "intends," "anticipates," "estimate," "future," "plan," "positioned," "potential," "project," "remain," "scheduled," "set to," "subject to," "upcoming," and similar expressions to help identify forward-looking statements. The forward-looking statements in this release are based upon information available to VANC as of the date of this release, and VANC assumes no obligation to update any such forward-looking statements. Forward-looking statements believed to be true when made may ultimately prove to be incorrect. These statements are not guarantees of the future performance of VANC and are subject to risks, uncertainties and other factors, some of which are beyond its control and may cause actual results to differ materially from current expectations.

Contact Information

  • VANC Pharmaceuticals Inc.
    Jamie Lewin
    Director and CFO
    604-687-3141 (FAX)